Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cognitive functions and hypertension].

O Hanon1, M L Seux, H Lenoir

  • 1Service de Gérontologie, Hôpital Broca, Paris. olivier.hanon@brc.ap-hop-paris.fr

Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 25, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perspectives of French community-dwelling older adults on the use of digital services: a qualitative study based on interviews.

BMC geriatrics·2026
Same author

Primary Impact Trajectories of a Psychoeducational Program for Nursing Home Caregivers: Insights from Clinical Case Studies.

International medical case reports journal·2025
Same author

The pattern of cortical thickness associated with executive dysfunction in MCI and SCC: The MEMENTO cohort.

Revue neurologique·2024
Same author

[Translation into French and republication of: "Management of cancer-associated thromboembolism in vulnerable population"].

La Revue de medecine interne·2024
Same author

The free plasma amyloid Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma Aβ<sub>1</sub><sub>-</sub><sub>42</sub>/Aβ<sub>1</sub><sub>-</sub><sub>40</sub> ratio. The BALTAZAR study.

Neurobiology of disease·2024
Same author

Orthostatic hypotension: Review and expert position statement.

Revue neurologique·2023
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

Hypertension is a key risk factor for cognitive decline and dementia. Antihypertensive treatments show promise in preventing dementia, highlighting the need to assess cognitive function in future studies.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Gerontology

Context:

  • Cognitive disorders and dementia prevention pose significant global health challenges.
  • Hypertension is a primary risk factor for cerebrovascular diseases, cognitive decline, and dementia.
  • Longitudinal studies indicate an inverse relationship between past blood pressure and current cognitive function.

Purpose:

  • To explore the role of hypertension in cognitive decline and dementia.
  • To evaluate the potential of antihypertensive treatments in dementia prevention.
  • To emphasize the importance of cognitive function assessment in hypertensive patient studies.

Summary:

  • Hypertension significantly contributes to cognitive impairment and dementia risk.
  • Evidence suggests that elevated blood pressure decades prior correlates with poorer cognitive function.

Related Experiment Videos

  • Therapeutic trials like SYST-EUR and PROGRESS indicate antihypertensive treatments may prevent dementia (vascular and Alzheimer's types).

    • Impact:

    • Antihypertensive therapies offer a potential strategy for dementia prevention.
    • Cognitive function assessment should be a primary endpoint in future studies of hypertensive patients.
    • This research underscores the link between cardiovascular health and brain health, impacting public health strategies.